MDxHealth SA (MDXH) - Financial and Strategic SWOT Analysis Review

MDxHealth SA (MDXH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

MDxHealth SA (MDxHealth) develops and commercializes advanced epigenetic and other molecular tests for cancer assessment and the personalized treatment of patients. The companys products portfolio includes ConfirmMDx, which detects absence or presence of prostate cancer; SelectMDx for prostate cancer; and AssureMDx for bladder cancer. Its pipeline products include InformMDx, and MonitorMDx which is being developed for Prostate Cancer Test. MdxHealth tests are based on MSP (Methylation-Specific polymerase chain reaction) technology, a proprietary DNA-based platform. It also offers biomarker development services to many pharmaceutical companies. MDxHealth markets its products through sales forces, partnerships and distributors. The company has operations in, the Netherlands, Belgium and the US. MDxHealth is headquartered in Herstal, Liege, Belgium.

MDxHealth SA Key Recent Developments

Aug 29,2019: MDxHealth reports half year 2019 financial results and strategic update
Apr 24,2019: MDxHealth provides Q1 2019 business update
Feb 28,2019: MDxHealth reports financial year 2018 results and provides outlook for 2019
Feb 19,2019: MDxHealth names Michael K. McGarrity as CEO
Jan 14,2019: MDxHealth provides business update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company




Section 1 - About the Company
MDxHealth SA - Key Facts
MDxHealth SA - Key Employees
MDxHealth SA - Key Employee Biographies
MDxHealth SA - Major Products and Services
MDxHealth SA - History
MDxHealth SA - Company Statement
MDxHealth SA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 Company Analysis
Company Overview
MDxHealth SA - Business Description
MDxHealth SA - Corporate Strategy
MDxHealth SA - SWOT Analysis
SWOT Analysis - Overview
MDxHealth SA - Strengths
MDxHealth SA - Weaknesses
MDxHealth SA - Opportunities
MDxHealth SA - Threats
MDxHealth SA - Key Competitors
Section 3 Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 Companys Lifesciences Financial Deals and Alliances
MDxHealth SA, Medical Equipment, Deals By Year, 2013 to YTD 2019
MDxHealth SA, Medical Equipment, Deals By Type, 2013 to YTD 2019
MDxHealth SA, Recent Deals Summary
Section 5 Companys Recent Developments
Aug 29, 2019: MDxHealth reports half year 2019 financial results and strategic update
Apr 24, 2019: MDxHealth provides Q1 2019 business update
Feb 28, 2019: MDxHealth reports financial year 2018 results and provides outlook for 2019
Feb 19, 2019: MDxHealth names Michael K. McGarrity as CEO
Jan 14, 2019: MDxHealth provides business update
Oct 23, 2018: MDxHealth provides business update for the first nine months of 2018
Aug 30, 2018: MDxHealth announces half year 2018 financial results
Apr 27, 2018: MDxHealth releases 2017 Annual Report
Apr 24, 2018: MDxHealth Reports First Quarter 2018 Financial Results
Mar 22, 2018: MDxHealth Successfully Completes a EUR 36 Million (USD 44 million)(1) Capital Increase
Section 6 Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables


MDxHealth SA, Key Facts
MDxHealth SA, Key Employees
MDxHealth SA, Key Employee Biographies
MDxHealth SA, Major Products and Services
MDxHealth SA, History
MDxHealth SA, Subsidiaries
MDxHealth SA, Key Competitors
MDxHealth SA, Ratios based on current share price
MDxHealth SA, Annual Ratios
MDxHealth SA, Annual Ratios (Cont...1)
MDxHealth SA, Interim Ratios
MDxHealth SA, Medical Equipment, Deals By Year, 2013 to YTD 2019
MDxHealth SA, Medical Equipment, Deals By Type, 2013 to YTD 2019
MDxHealth SA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures


MDxHealth SA, Performance Chart (2014 - 2018)
MDxHealth SA, Ratio Charts
MDxHealth SA, Medical Equipment, Deals By Year, 2013 to YTD 2019
MDxHealth SA, Medical Equipment, Deals by Type, 2013 to YTD 2019

MDxHealth SA (MDXH) - Product Pipeline Analysis, 2019 Update

MDxHealth SA (MDxHealth) develops and commercializes advanced epigenetic and other molecular tests for cancer assessment and the personalized treatment of patients. The companys products portfolio includes ConfirmMDx, which detects absence

USD 750 View Report

MDxHealth SA (MDXH) - Product Pipeline Analysis, 2018 Update

MDxHealth SA (MDxHealth) develops and commercializes advanced epigenetic and other molecular tests for cancer assessment and the personalized treatment of patients. The companys products portfolio includes ConfirmMDx, which detects absence

USD 750 View Report

MDxHealth SA (MDXH) - Product Pipeline Analysis, 2019 Update

MDxHealth SA (MDxHealth) develops and commercializes advanced epigenetic and other molecular tests for cancer assessment and the personalized treatment of patients. The companys products portfolio includes ConfirmMDx, which detects absence

USD 750 View Report

MDxHealth SA (MDXH) - Product Pipeline Analysis, 2018 Update

MDxHealth SA (MDxHealth) develops and commercializes advanced epigenetic and other molecular tests for cancer assessment and the personalized treatment of patients. The companys products portfolio includes ConfirmMDx, which detects absence

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available